期刊文献+

丹参联合易善复对肝炎合并肝癌术后残肝的临床研究

Effects of essentials plus red saqe root on virus hepatitis complicated with liver cancer
下载PDF
导出
摘要 目的评价丹参联合易善复干预肝炎后肝癌术后残肝的临床疗效。方法选择病毒性乙型肝炎合并肝癌患者72例,随机分为2组。对照组32例,采用口服益肝灵、维生素类护肝药、静脉滴注能量合剂、门冬氨酸钾镁,酌情应用氨基酸、白蛋白等治疗。治疗组40例,在对照组治疗基础上应用易善复和复方丹参片治疗,均2个月为1个疗程。观察2组治疗效果。结果治疗组总有效率为97.5%明显高于对照组的62.5%,差异有统计学意义(P<0.01)。治疗组肝功能(ALT、TST、TBiL)、肝癌指标及临床症状等项目的改善均明显优于对照组(P<0.01或P<0.05),且无明显不良反应。结论丹参联合易善复治疗病毒性肝炎合并肝癌对促进肝脏脂类代谢、降低病毒复制量、修复损伤的肝细胞及阻止或改善肝癌均有明显的功效。 Objective To evaluate the therapeutic effect essentials and red saqe root on virus hepatitis merging hepatic fibrosis. Methods 72 patients with virus hepatitis complicated with liver cancer were divided into therapeutic group ( n = 40) and control group( n = 32) randomly. Patiens of the two groups were all given specific treatment. The course of therapy is 2 months. Results There were significant difference in total effeciency between two groups(97.5% vs 62.5%, P 〈 0.01 ). ALT, TBiL, hepatic fibrosis and clinical symptom in therapeutic group were obviously improved. There was significant difference between the two groups. ( P 〈 0.05 or P 〈 0.1 ) and there were no obviously vice - reaction. Conclusion Essentials plus red saqe root can promote the grease's metabolism of liver , repair damage of hepatic cell and prevent the progress of hepatic fibrosis.
出处 《临床合理用药杂志》 2009年第7期12-13,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 病毒性肝炎 肝癌 易善复 丹参 Virus hepatitis liver cancer Sential Red saqe root
  • 相关文献

参考文献4

二级参考文献32

  • 1叶红军,高永生,王丽英,肖红,计秀生,潘春芝,冯雪梅.血清Ⅲ型前胶原对肝纤维化的诊断价值[J].临床肝胆病杂志,1993,9(2):90-92. 被引量:65
  • 2Wu J, Zern MA. Hepatic stellate cells: a target treatment of liver fibrosis, Gastroenterol.2000, 35 (9): 666-672.
  • 3Schuppan D, Strobel D, Hahn EG.Hepatic fibrosis - therapeutic strategies.Digestion, 1998, 59:385-390.
  • 4Qi Z, Atsushi N, Doshima A, et al. Blockade of type beta transtomaing growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA, 1999, 96 (5): 2345- 2349.
  • 5Inagaki Y, Mamura M, Kanarnaru Y, et al. Constitutive phosphorylation mad nuclear localization of Smad3 are correlated with incread collagen gene transcription in activated hepatic stellate cells.Cell Phys;ol2001, 187 (1): 117-123.
  • 6Dooley S, Delvoux B, Lahme B, et al. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology, 2000, 31 (5) :1094- 1106.
  • 7Stopa M, Benes V, Ansorge W, et al. Gentle locus and promoter region of rat Smad7, an important antagonist of TGF beta signaling. Mamm Genome, 2000, 11 : 169-176.
  • 8Raftery LA, Twombly V, Wharton K, et al. Genetic screens to identity elements of the decapentaplegic signaling pathway in Drosophila.Genetics, 1995, 139 (1): 241-254.
  • 9Sekelsky J J, Newfeld SJ, Raftery LA, et od. Genetic characterization and cloning of mothers agaist dpp, a gene required for decapentaplegic function in Drosophila melanogaster.Geneties, 1995, 139 (3): 1347- 1358.
  • 10Schnabl B, Kweon Yo, Frederick JP, et al. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology, 2001, (1): 89-100.

共引文献487

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部